Logo image of PL

PLANET LABS PBC (PL) Stock Fundamental Analysis

NYSE:PL - New York Stock Exchange, Inc. - US72703X1063 - Common Stock - Currency: USD

3.99  +0.15 (+3.91%)

Premarket: 4.82 +0.83 (+20.8%)

Fundamental Rating

3

Taking everything into account, PL scores 3 out of 10 in our fundamental rating. PL was compared to 82 industry peers in the Professional Services industry. While PL seems to be doing ok healthwise, there are quite some concerns on its profitability. PL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

PL had negative earnings in the past year.
In the past year PL has reported a negative cash flow from operations.
In the past 5 years PL always reported negative net income.
PL had a negative operating cash flow in each of the past 5 years.
PL Yearly Net Income VS EBIT VS OCF VS FCFPL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

PL has a worse Return On Assets (-19.44%) than 82.93% of its industry peers.
PL has a worse Return On Equity (-27.92%) than 79.27% of its industry peers.
Industry RankSector Rank
ROA -19.44%
ROE -27.92%
ROIC N/A
ROA(3y)-20.33%
ROA(5y)-21.9%
ROE(3y)-27.72%
ROE(5y)-44.51%
ROIC(3y)N/A
ROIC(5y)N/A
PL Yearly ROA, ROE, ROICPL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 57.72%, PL is in the better half of the industry, outperforming 69.51% of the companies in the same industry.
PL's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for PL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.26%
GM growth 5YN/A
PL Yearly Profit, Operating, Gross MarginsPL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100

6

2. Health

2.1 Basic Checks

PL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PL has more shares outstanding
PL has more shares outstanding than it did 5 years ago.
There is no outstanding debt for PL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PL Yearly Shares OutstandingPL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M
PL Yearly Total Debt VS Total AssetsPL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

PL has an Altman-Z score of 1.24. This is a bad value and indicates that PL is not financially healthy and even has some risk of bankruptcy.
PL has a worse Altman-Z score (1.24) than 70.73% of its industry peers.
There is no outstanding debt for PL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.24
ROIC/WACCN/A
WACC9.1%
PL Yearly LT Debt VS Equity VS FCFPL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

PL has a Current Ratio of 2.13. This indicates that PL is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.13, PL is doing good in the industry, outperforming 79.27% of the companies in the same industry.
PL has a Quick Ratio of 2.13. This indicates that PL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.13, PL is in the better half of the industry, outperforming 79.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 2.13
PL Yearly Current Assets VS Current LiabilitesPL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.43% over the past year.
Looking at the last year, PL shows a quite strong growth in Revenue. The Revenue has grown by 10.72% in the last year.
The Revenue has been growing by 20.62% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)10.72%
Revenue growth 3Y23.03%
Revenue growth 5Y20.62%
Sales Q2Q%9.65%

3.2 Future

The Earnings Per Share is expected to grow by 25.10% on average over the next years. This is a very strong growth
Based on estimates for the next years, PL will show a quite strong growth in Revenue. The Revenue will grow by 17.88% on average per year.
EPS Next Y12.7%
EPS Next 2Y20.61%
EPS Next 3Y25.1%
EPS Next 5YN/A
Revenue Next Year10.63%
Revenue Next 2Y15.93%
Revenue Next 3Y17.88%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
PL Yearly Revenue VS EstimatesPL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
PL Yearly EPS VS EstimatesPL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PL Price Earnings VS Forward Price EarningsPL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PL Per share dataPL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as PL's earnings are expected to grow with 25.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.61%
EPS Next 3Y25.1%

0

5. Dividend

5.1 Amount

No dividends for PL!.
Industry RankSector Rank
Dividend Yield N/A

PLANET LABS PBC

NYSE:PL (6/4/2025, 8:04:01 PM)

Premarket: 4.82 +0.83 (+20.8%)

3.99

+0.15 (+3.91%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)06-04 2025-06-04/amc
Earnings (Next)09-03 2025-09-03/amc
Inst Owners57.97%
Inst Owner Change5.45%
Ins Owners2.57%
Ins Owner Change3.94%
Market Cap1.21B
Analysts82.11
Price Target5.64 (41.35%)
Short Float %3.48%
Short Ratio2.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-83.24%
Min EPS beat(2)-217.93%
Max EPS beat(2)51.46%
EPS beat(4)3
Avg EPS beat(4)-32.95%
Min EPS beat(4)-217.93%
Max EPS beat(4)51.46%
EPS beat(8)7
Avg EPS beat(8)-6.37%
EPS beat(12)10
Avg EPS beat(12)-1.36%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.59%
Min Revenue beat(2)-5.77%
Max Revenue beat(2)-3.41%
Revenue beat(4)0
Avg Revenue beat(4)-3.87%
Min Revenue beat(4)-5.77%
Max Revenue beat(4)-2.26%
Revenue beat(8)0
Avg Revenue beat(8)-3.36%
Revenue beat(12)2
Avg Revenue beat(12)-1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-104.17%
EPS NY rev (1m)0%
EPS NY rev (3m)-130.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.94
P/FCF N/A
P/OCF N/A
P/B 2.73
P/tB 4.67
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.81
BVpS1.46
TBVpS0.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.44%
ROE -27.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.72%
FCFM N/A
ROA(3y)-20.33%
ROA(5y)-21.9%
ROE(3y)-27.72%
ROE(5y)-44.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.26%
GM growth 5YN/A
F-Score5
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 108.73%
Cap/Sales 20.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 2.13
Altman-Z 1.24
F-Score5
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)75.73%
Cap/Depr(5y)61.76%
Cap/Sales(3y)15.4%
Cap/Sales(5y)16.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y12.7%
EPS Next 2Y20.61%
EPS Next 3Y25.1%
EPS Next 5YN/A
Revenue 1Y (TTM)10.72%
Revenue growth 3Y23.03%
Revenue growth 5Y20.62%
Sales Q2Q%9.65%
Revenue Next Year10.63%
Revenue Next 2Y15.93%
Revenue Next 3Y17.88%
Revenue Next 5YN/A
EBIT growth 1Y34.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year83.93%
EBIT Next 3Y42.67%
EBIT Next 5YN/A
FCF growth 1Y31.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.66%
OCF growth 3YN/A
OCF growth 5YN/A